Lukasz Matusiak
Wroclaw, DS 50981, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 144 publications
Illness Acceptance Among Adults with Melanoma: A Prospective Observational Cross-Sectional Study.
Journal: Cancers
Published: July 15, 2026
Illness Acceptance in Patients with Hidradenitis Suppurativa Depends on Disease Severity and Psychosocial Parameters: An Observational Cross-Sectional Study.
Journal: Journal of clinical medicine
Published: June 20, 2026
Does Alexithymia Affect Patients with Hidradenitis Suppurativa?
Journal: Clinical, cosmetic and investigational dermatology
Published: April 08, 2026
Hidradenitis Suppurativa Changes Major Life Decisions of Affected Patients: A Cross-sectional Study.
Hidradenitis Suppurativa Changes Major Life Decisions of Affected Patients: A Cross-sectional Study.
Journal: Acta dermato-venereologica
Published: February 17, 2026
Cutaneous Tuberculosis in the Modern Era: A Case of Lupus Vulgaris with Surgical Management and a Review of Clinical Spectrum, Diagnostic Challenges, and Malignant Potential.
Journal: Journal of clinical medicine
Published: December 03, 2025
A Cross-Sectional Study on Relationships Between Depression and Anxiety in Hidradenitis Suppurativa Patients and Disease Severity, Subjective Symptoms and Quality of Life.
Journal: Journal of clinical medicine
Published: November 29, 2025
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi Approach.
Journal: JAMA dermatology
Published: November 26, 2025
Familial hidradenitis suppurativa is associated with an increased prevalence of metabolic and cardiovascular comorbidity.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: October 23, 2025
Delphi consensus: First-line use of biologics and small molecules in hidradenitis suppurativa.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 24, 2025
An evaluation of bimekizumab for the treatment of hidradenitis suppurativa.
Journal: Expert opinion on biological therapy
Published: June 17, 2025
Eruptive melanocytic nevi induced by anti-BRAF therapy.
Journal: Polish archives of internal medicine
Published: June 02, 2025
Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologics.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 11, 2025
Last Updated: 09/26/2026